Back to Market Feed

Product Information

MESALAMINE DR 400 MG CAPSULE is a generic product labeled by Greenstone LLC, priced at $2.4352 per EA under NDC 59762011701. Its NADAC has been published 368 times since Jul 17, 2019.

FDA first approved this application on Feb 1, 2013.

MESALAMINE DR 400 MG CAPSULE

MESALAMINE
$2.4352per EA
Discontinued

Strength

400 mg/1

Manufacturer

Greenstone LLC

NDC

59762011701

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

7/22/2026

Active Ingredients

MESALAMINE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA204412

FDA Approved

2/1/2013

On Market Since

5/10/2019

Pharmacological Classes

Aminosalicylate
Aminosalicylic Acids

Price Statistics

The NADAC for MESALAMINE DR 400 MG CAPSULE has been published 368 times since Jul 17, 2019, and over the history we have for it it has declined 5.0%. The table below summarizes its recorded NADAC range and movement.

Current price$2.4352 per EA
All-time high$2.5848 (May 11, 2022)
All-time low$1.5286 (Jul 17, 2024)
52-week high$2.4352
52-week low$2.0896
Median price$2.1093
Average price$2.1087
Largest weekly change+29.8% (Aug 21, 2024)
Weeks tracked368
Tracking sinceJul 17, 2019

Price History

1W

N/A

1M

0.0%

3M

+1.2%

6M

+14.8%

1Y

+9.3%

3Y

+15.6%

5Y

+22.7%

All

-5.0%

Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MESALAMINE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

MESALAMINE 4 GM/60 ML ENEMA
Generic
21922004547•Encube Ethicals, Inc.
$0.0974
per ML
MESALAMINE 4 GM/60 ML ENEMA
Generic
45802009851•Padagis Israel Pharmaceuticals Ltd
$0.0974
per ML
MESALAMINE 4 GM/60 ML ENEMA
Generic
62559042007•ANI Pharmaceuticals, Inc.
$0.0974
per ML
MESALAMINE 4 GM/60 ML ENEMA
Generic
21922004549•Encube Ethicals, Inc.
$0.1789
per ML
MESALAMINE 4 GM/60 ML ENEMA
Generic
45802009828•Padagis Israel Pharmaceuticals Ltd
$0.1789
per ML
SULFASALAZINE 500 MG TABLET
Generic
00093323401•Teva Pharmaceuticals USA Inc.
$0.2003
per EA
SULFASALAZINE 500 MG TABLET
Generic
00093323405•Teva Pharmaceuticals USA Inc.
$0.2003
per EA
SULFASALAZINE 500 MG TABLET
Generic
00093323410•Teva Pharmaceuticals USA Inc.
$0.2003
per EA
SULFASALAZINE 500 MG TABLET
Generic
11534020001•Sunrise Pharmaceutical Inc.
$0.2003
per EA
SULFASALAZINE 500 MG TABLET
Generic
11534020004•Sunrise Pharmaceutical Inc.
$0.2003
per EA

Frequently asked questions

What is the NADAC price of MESALAMINE DR 400 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE DR 400 MG CAPSULE, manufactured by Greenstone LLC, is $2.4352 per EA (NDC 59762011701), effective Jul 29, 2026.

How has the price of MESALAMINE DR 400 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for MESALAMINE DR 400 MG CAPSULE has declined 5.0%. It has been tracked across 368 weekly CMS publications since Jul 17, 2019.

What are the highest and lowest recorded NADAC prices for MESALAMINE DR 400 MG CAPSULE?

Since Jul 17, 2019, the NADAC for MESALAMINE DR 400 MG CAPSULE has ranged from a low of $1.5286 (Jul 17, 2024) to a high of $2.5848 (May 11, 2022), with a median of $2.1093 per EA.

Are there cheaper alternatives to MESALAMINE DR 400 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of MESALAMINE DR 400 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures MESALAMINE DR 400 MG CAPSULE?

MESALAMINE DR 400 MG CAPSULE (NDC 59762011701) is labeled by Greenstone LLC, and CMS classifies it as a generic product.